Our findings contrast with previous studies in vitro, which demonstrated that ectopic expression of TFPI-2 significantly inhibited cell proliferation in hepatocellular carcinoma [11], nasopharyngeal carcinoma [10] cell lines and Human retinal endothelial cells [32]. Here, TFPI2 is linked to hepatocellular carcinoma.